Two multibillion-dollar healthcare acquisitions yesterday brought the tally of both US and global healthcare mergers and acquisitions volume this year to a six-year high.

McKesson bought healthcare transaction processor Per Se Technologies for $1.87bn (€1.47bn) and Abbott agreed to buy cholesterol drug maker Kos Pharmaceuticals for $3.85bn.